159 related articles for article (PubMed ID: 12176556)
21. Oral vs intravenous tacrolimus-based induction therapy in renal transplantation.
Tojimbara T; Kimikawa M; Nakajima I; Sato S; Nakamura M; Ishida H; Tanabe K; Koyama I; Utsumi K; Sannomiya A; Tsuji K; Fuchinoue S; Agishi T
Transplant Proc; 1999 Nov; 31(7):2763-4. PubMed ID: 10578282
[No Abstract] [Full Text] [Related]
22. Tacrolimus-based immunosuppression in renal transplantation: 78 experiences in a single Japanese center.
Okamoto M; Omori Y; Kadotani Y; Ushigome H; Nakamura K; Akioka K; Yoshimura N
Transplant Proc; 2002 Aug; 34(5):1666. PubMed ID: 12176527
[No Abstract] [Full Text] [Related]
23. Tacrolimus trough level adjustment after administration of fluconazole to kidney recipients.
Toda F; Tanabe K; Ito S; Shinmura H; Tokumoto T; Ishida H; Toma H
Transplant Proc; 2002 Aug; 34(5):1733-5. PubMed ID: 12176555
[No Abstract] [Full Text] [Related]
24. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic monitoring of tacrolimus in pediatric and adult transplanted patients.
Capone D; Gentile A; Vajro P; Stanziale P; Imperatore P; De Silva C; Pellegrino T; Basile V
J Chemother; 1998 Apr; 10(2):176-8. PubMed ID: 9603651
[No Abstract] [Full Text] [Related]
26. Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients.
Hesse CJ; Baan CC; Balk AH; Metselaar HJ; Weimar W; van Gelder T
Transplant Proc; 2002 Nov; 34(7):2988-90. PubMed ID: 12431679
[No Abstract] [Full Text] [Related]
27. Alterations in calcineurin phosphatase activity in tacrolimus-treated renal transplant patients.
Koefoed-Nielsen PB; Jørgensen KA
Transplant Proc; 2002 Aug; 34(5):1743-4. PubMed ID: 12176559
[No Abstract] [Full Text] [Related]
28. Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus.
Braun F; Lorf T; Schütz E; Christians U; Grupp C; Sattler B; Canelo R; Sewing KF; Armstrong VW; Oellerich M; Ringe B
Transplant Proc; 1996 Dec; 28(6):3175-6. PubMed ID: 8962231
[No Abstract] [Full Text] [Related]
29. Conversion to rapamycin in renal allograft recipients with biopsy-proven calcineurin inhibitor-induced nephrotoxicity.
Diekmann F; Waiser J; Fritsche L; Dragun D; Neumayer HH; Budde K
Transplant Proc; 2001; 33(7-8):3234-5. PubMed ID: 11750386
[No Abstract] [Full Text] [Related]
30. Tacrolimus dosing requirements in diabetic and nondiabetic patients calculated from pretransplantation data.
van Duijnhoven E; Christiaans M; Schäfer A; Undre N; van Hooff J
Transplant Proc; 1998 Jun; 30(4):1266-7. PubMed ID: 9636514
[No Abstract] [Full Text] [Related]
31. Clinical influencing factors for daily dose, trough level, and relative clearance of tacrolimus in renal transplant recipients.
Hu RH; Lee PH; Tsai MK
Transplant Proc; 2000 Nov; 32(7):1689-92. PubMed ID: 11119894
[No Abstract] [Full Text] [Related]
32. Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.
Kokado Y; Takahara S; Kyo M; Ichimaru N; Toki K; Wang JD; Okuyama A
Transplant Proc; 1999; 31(1-2):1151-4. PubMed ID: 10083515
[No Abstract] [Full Text] [Related]
33. Evidence that fasting does not significantly affect trough levels of tacrolimus in stable renal transplant recipients.
van Duijnhoven EM; Christiaans MH; Boots JM; van Hooff JP
Transplant Proc; 2002 Aug; 34(5):1723-5. PubMed ID: 12176552
[No Abstract] [Full Text] [Related]
34. Pharmacokinetics of tacrolimus in paediatric renal transplant recipients.
Webb NJ; Stevenson PJ; Lewis MA; Postlethwaite RJ; Bradbury MG; Undre N
Transplant Proc; 2002 Aug; 34(5):1948-50. PubMed ID: 12176639
[No Abstract] [Full Text] [Related]
35. Japanese study of FK 506 on kidney transplantation: 2. Follow-up study of FK 506-treated patients.
Transpl Int; 1992; 5 Suppl 1():S552-5. PubMed ID: 14621874
[TBL] [Abstract][Full Text] [Related]
36. FK506 rescue therapy for acute renal allograft rejection.
Goh BL; Morad Z; Cheah PL; Chua CT; Tan SY
Transplant Proc; 1998 Nov; 30(7):3592-3. PubMed ID: 9838574
[No Abstract] [Full Text] [Related]
37. Therapeutic drug monitoring of once-daily tacrolimus (Advagraf) in a gastrectomized kidney transplant recipient.
Ma TK; Chow KM; Kwan BC; Leung CB; Szeto CC; Li PK
Nephrology (Carlton); 2017 Feb; 22(2):184. PubMed ID: 28064453
[No Abstract] [Full Text] [Related]
38. Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal.
Cronin DC; Bruce DS; Newell KA; Josephson MA; Millis JM; Piper JB; Ruebe M; Kirby M; Thistlethwaite JR; Woodle ES
Transplant Proc; 1997; 29(1-2):307. PubMed ID: 9123010
[No Abstract] [Full Text] [Related]
39. C2 (2-h) levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal-transplant patients.
Jørgensen K; Povlsen J; Madsen S; Madsen M; Hansen H; Pedersen A; Heinsvig EM; Poulsen J
Nephrol Dial Transplant; 2002 Aug; 17(8):1487-90. PubMed ID: 12147799
[TBL] [Abstract][Full Text] [Related]
40. Optimal use of tacrolimus in living donor renal transplantation in children.
Hasegawa A; Takahashi K; Ito K; Oshima S; Uchida K; Sonoda T;
Transplant Proc; 2002 Aug; 34(5):1939-41. PubMed ID: 12176635
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
